Inflammatory mediators like TNF-α and IL-1β can impede insulin signaling pathways, intensifying insulin resistance and ultimately contributing to the advancement of T2DM and the onset of associated complications [8]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.